Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Blood|May 1, 2012
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyJudith C Marsh, Andrea Bacigalupo, Hubert Schrezenmeier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.Bone Marrow Transplantation|November 29, 2025
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working PartyMarta Villalba, Allain-Thibeault Ferhat, Tobias Gedde-Dahl, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group reportAlexandra H Filipovich, Daniel Weisdorf, Steven Pavletic, et al.American Journal of Hematology|December 23, 2015
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment studyMichael Loschi, Raphael Porcher, Fiorenza Barraco, et al.Transplantation and Cellular Therapy|April 9, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group ReportJoseph Pidala, Carrie Kitko, Stephanie J Lee, et al.Transplantation and Cellular Therapy|April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group ReportCarrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.Transplantation and Cellular Therapy|June 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD ReportZachariah DeFilipp, Daniel R Couriel, Aleksandr Lazaryan, et al.British Journal of Haematology|July 31, 2015
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMTCarlo Dufour, Paul Veys, Elisa Carraro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemiaMouhab Ayas, Wael Saber, Stella M Davies, et al.Pageof 8